These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6518967)

  • 1. Effect of hyperbilirubinaemia on the plasma protein binding of chlorophenoxyisobutyric acid in neonates.
    Barré J; Houin G; Shastri RA; Benattar C; Lindenbaum A; Tillement JP
    Dev Pharmacol Ther; 1984; 7 Suppl 1():26-9. PubMed ID: 6518967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the blood protein bilirubin binding capacity in jaundice of the newborn].
    Punchenok NA; Nikitina II
    Vopr Okhr Materin Det; 1980 Jan; 25(1):26-9. PubMed ID: 7385651
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of food on the absorption of the p-chlorophenolic ester of chlorophenoxyisobutyric acid in man.
    Houin G; Shastri RA; Barre J; Pinchon B; Tillement JP
    Br J Clin Pharmacol; 1984 Mar; 17(3):341-5. PubMed ID: 6712867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the residual binding capacity of protein in icterus of the newborn].
    Cislaghi GU; Magni LA
    Minerva Pediatr; 1969 Feb; 21(7):259-61. PubMed ID: 5797179
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous GLC determination of clofibrate and clofibric acid in human plasma.
    Wolf MS; Zimmerman JJ
    J Pharm Sci; 1980 Jan; 69(1):92-3. PubMed ID: 7354454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the bilirubin-binding capacity in the serum of icteric newborn infants. Critical review?].
    Priolisi A
    Minerva Pediatr; 1976 Nov; 28(35):2117-27. PubMed ID: 1012231
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilirubin crystals in peripheral blood smears from neonates with unconjugated hyperbilirubinaemia.
    Marwaha N; Sarode R; Marwaha RK; Sharma S; Yachha S; Narang A
    Med Lab Sci; 1990 Oct; 47(4):278-81. PubMed ID: 2283930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products.
    Altmayer P; Garrett ER
    J Pharm Sci; 1983 Nov; 72(11):1309-18. PubMed ID: 6644594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients.
    Bjornsson TD; Meffin PJ; Peters FA; Blaschke TF
    Clin Pharmacol Ther; 1980 Feb; 27(2):230-5. PubMed ID: 7353345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reserve binding capacity of plasma in premature children with hyperbilirubinemia].
    Marakina SP; Tabolin VA
    Pediatriia; 1977 May; (5):39-41. PubMed ID: 876758
    [No Abstract]   [Full Text] [Related]  

  • 11. The simultaneous analysis of clofibric acid and probenecid and the direct analysis of clofibric acid glucuronide by high-performance liquid chromatography.
    Veenendaal JR; Meffin PJ
    J Chromatogr; 1981 Apr; 223(1):147-54. PubMed ID: 7251756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drug binding on the esterase-like activity of human serum albumin. III. Evaluation of reactivities of the two active sites by using clofibric acid as an inhibitor.
    Kurono Y; Ohta N; Yotsuyanagi T; Ikeda K
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2345-50. PubMed ID: 7318041
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B; Di Giulio S; Nicolaï A; Drüeke T; Debray M; Boulu RG
    Nephrologie; 1982; 3(1):19-22. PubMed ID: 7088259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of unbound bilirubin concentration to reserve albumin-binding concentration for bilirubin in human neonatal plasma.
    Karp WB; Robertson AF; Davis HC
    Biol Neonate; 1984; 46(3):105-9. PubMed ID: 6466747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of clofibric acid in blood after the administration of delayed-release form of etofibrate.
    Vazquez Lopez F; Armijo Castro F; Pire Solis I; Gutierrez Fuentes JA
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):31-5. PubMed ID: 3557726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of protein metabolism in neonatal hyperbilirubinemia and their correction by extracorporeal detoxification].
    Ten VS; Mazur LI; Nikolaĭchik VV; Moiseev AN
    Pediatriia; 1989; (6):29-33. PubMed ID: 2762050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of [14C]clofibric acid glucuronide and [14C]clofibric acid in plasma and urine using high-performance liquid chromatography.
    Meffin PJ; Zilm DM
    J Chromatogr; 1983 Nov; 278(1):101-8. PubMed ID: 6662867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate neonatal hyperbilirubinaemia: hold tight.
    Lancet; 1991 Nov; 338(8777):1242-3. PubMed ID: 1682649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive treatment of jaundice in premature newborn infants with clofibrate. Double-blind controlled therapeutic trial].
    Lindenbaum A; Delaporte B; Benattar C; Dehan M; Magny JF; Gerbet D; Leluc R; Gabilan JC
    Arch Fr Pediatr; 1985 Nov; 42(9):759-63. PubMed ID: 3909977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomes.
    Dragacci S; Hamar-Hansen C; Fournel-Gigleux S; Lafaurie C; Magdalou J; Siest G
    Biochem Pharmacol; 1987 Nov; 36(22):3923-7. PubMed ID: 3120730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.